Search Count: 49
 |
Trastuzumab Fab V3 In Complex With 5-Phenyl Meditope Variant
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-09-05
 |
Trastuzumab Fab V3
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION
Release Date: 2018-09-05
 |
Trastuzumab Fab V3 In Complex With Cqfdlstrrlkc
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-09-05
 |
Trastuzumab Fab V3 With 5-Diphenyl Meditope Variant
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-09-05
 |
Structure Of Meditope Enabled Trastuzumab I83E Variant
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
 |
Meditope Enabled Trastuzumab I83E Variant In Complex With (Ac) Cqfda(Ph)2Strrlrcggsk
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
 |
Crystal Structure Of I83E Meditope-Enabled Trastuzumab With Azido-Meditope
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
 |
Crystal Structure Of I83E Meditope-Enabled Trastuzumab With Azido-Peg3-Meditope
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
 |
Structure Of Cetuximab With Aminoheptanoic Acid-Linked N-Butylarginine Meditope Variant
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2017-12-13 Classification: IMMUNE SYSTEM Ligands: SO4 |
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2017-12-13
Ligands: SO4
 |
Structure Of Cetuximab With Aminoheptanoic Acid-Linked N-Octylarginine Meditope Variant
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2017-12-13 Classification: IMMUNE SYSTEM Ligands: SO4 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2017-12-13
Ligands: SO4
 |
Structure Of Cetuximab With Aminoheptanoic Acid-Linked N-(3-Aminopropyl)-L-Arginine Meditope Variant
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2017-12-13 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2017-12-13
 |
Structure Of Cetuximab With Aminoheptanoic Acid-Linked N-(3-Hydroxypropyl)-L-Arginine Meditope Variant
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2017-12-13 Classification: IMMUNE SYSTEM Ligands: SO4 |
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2017-12-13
Ligands: SO4
 |
Structure Of Cetuximab With Aminoheptanoic Acid-Linked N-Carboxyethylarginine Meditope Variant
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2017-12-13 Classification: IMMUNE SYSTEM Ligands: SO4 |
Organism: Mus musculus, Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2017-12-13
Ligands: SO4
 |
Cetuximab Fab In Complex With L5E Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
 |
Cetuximab Fab In Complex With F3H Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG, MRY |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG, MRY
 |
Cetuximab Fab In Complex With L5Y Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
 |
Cetuximab Fab In Complex With L10Q Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
 |
Structure Of Cetuximab Fab With Cyclic F3Q Variant Of The Meditope
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
 |
Cetuximab Fab In Complex With 4-Bromophenylalanine Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
 |
Cetuximab Fab In Complex With 3-Bromophenylalanine Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG